The FDA's 2023-2025 overhaul of generic drug approval is reshaping U.S. pharmaceutical supply chains. Faster reviews, domestic manufacturing incentives, and first-generic boosts are lowering prices and preventing shortages.
Read more© 2026. All rights reserved.